Cargando…
Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614316/ https://www.ncbi.nlm.nih.gov/pubmed/37915024 http://dx.doi.org/10.1186/s12943-023-01890-z |
| _version_ | 1785129002399170560 |
|---|---|
| author | McDermott, Martina S. J. Browne, Brigid C. Conlon, Neil T. O’Brien, Neil A. Slamon, Dennis J. Henry, Michael Meleady, Paula Clynes, Martin Dowling, Paul Crown, John O’Donovan, Norma |
| author_facet | McDermott, Martina S. J. Browne, Brigid C. Conlon, Neil T. O’Brien, Neil A. Slamon, Dennis J. Henry, Michael Meleady, Paula Clynes, Martin Dowling, Paul Crown, John O’Donovan, Norma |
| author_sort | McDermott, Martina S. J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10614316 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106143162023-10-31 Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy McDermott, Martina S. J. Browne, Brigid C. Conlon, Neil T. O’Brien, Neil A. Slamon, Dennis J. Henry, Michael Meleady, Paula Clynes, Martin Dowling, Paul Crown, John O’Donovan, Norma Mol Cancer Correction BioMed Central 2023-10-30 /pmc/articles/PMC10614316/ /pubmed/37915024 http://dx.doi.org/10.1186/s12943-023-01890-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction McDermott, Martina S. J. Browne, Brigid C. Conlon, Neil T. O’Brien, Neil A. Slamon, Dennis J. Henry, Michael Meleady, Paula Clynes, Martin Dowling, Paul Crown, John O’Donovan, Norma Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy |
| title | Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy |
| title_full | Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy |
| title_fullStr | Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy |
| title_full_unstemmed | Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy |
| title_short | Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy |
| title_sort | correction: pp2a inhibition overcomes acquired resistance to her2 targeted therapy |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614316/ https://www.ncbi.nlm.nih.gov/pubmed/37915024 http://dx.doi.org/10.1186/s12943-023-01890-z |
| work_keys_str_mv | AT mcdermottmartinasj correctionpp2ainhibitionovercomesacquiredresistancetoher2targetedtherapy AT brownebrigidc correctionpp2ainhibitionovercomesacquiredresistancetoher2targetedtherapy AT conlonneilt correctionpp2ainhibitionovercomesacquiredresistancetoher2targetedtherapy AT obrienneila correctionpp2ainhibitionovercomesacquiredresistancetoher2targetedtherapy AT slamondennisj correctionpp2ainhibitionovercomesacquiredresistancetoher2targetedtherapy AT henrymichael correctionpp2ainhibitionovercomesacquiredresistancetoher2targetedtherapy AT meleadypaula correctionpp2ainhibitionovercomesacquiredresistancetoher2targetedtherapy AT clynesmartin correctionpp2ainhibitionovercomesacquiredresistancetoher2targetedtherapy AT dowlingpaul correctionpp2ainhibitionovercomesacquiredresistancetoher2targetedtherapy AT crownjohn correctionpp2ainhibitionovercomesacquiredresistancetoher2targetedtherapy AT odonovannorma correctionpp2ainhibitionovercomesacquiredresistancetoher2targetedtherapy |